
Live Regeneron Pharmaceuticals Tokenized Stock (Ondo) price
Regeneron Pharmaceuticals Tokenized Stock (Ondo) price chart
Regeneron Pharmaceuticals Tokenized Stock (Ondo) (REGNon) price details

Regeneron Pharmaceuticals Tokenized Stock (Ondo) price history
Regeneron Pharmaceuticals Tokenized Stock (Ondo) technical analysis

Regeneron Pharmaceuticals Tokenized Stock (Ondo) (REGNon) sentiment
About Regeneron Pharmaceuticals Tokenized Stock (Ondo)
Regeneron Pharmaceuticals Tokenized Stock (Ondo) (REGNON) Introduction
Regeneron Pharmaceuticals Tokenized Stock (Ondo) (REGNON) represents a tokenized version of Regeneron Pharmaceuticals' stock, ticker REGN, on the blockchain. As per CoinMarketCap data extracted on March 31, 2026, its live price stands at $745.53 USD, with a 24-hour trading volume of $33,575.65 USD and a slight 0.92% decline. The token's market cap is $109.54 USD, with a circulating supply of about 0.147 REGNON coins and no maximum supply defined. Ranked #3719 on CoinMarketCap, REGNON offers synthetic exposure to Regeneron's performance in biotech, focusing on treatments for diseases like COVID-19 and eye conditions. Ondo Finance powers this by tokenizing assets, making them accessible globally via Ethereum, as seen on Etherscan. This setup appeals to crypto enthusiasts seeking diversified portfolios without traditional barriers.
How does Regeneron Pharmaceuticals Tokenized Stock (Ondo) Crypto Work?
Regeneron Pharmaceuticals Tokenized Stock (Ondo) (REGNON) operates through Ondo Finance's tokenization protocol on the Ethereum blockchain. Users mint REGNON by depositing collateral, gaining exposure to REGN stock's price and dividends, which are automatically reinvested. This synthetic asset mirrors REGN's performance via smart contracts, ensuring 24/5 liquidity from traditional exchanges. As explained in Ondo Finance's documentation, restrictions apply to US persons for regulatory compliance. The token's value tracks Regeneron's stock, influenced by biotech innovations like monoclonal antibodies. Blockchain explorers like Etherscan verify transactions, promoting transparency. Unlike direct stock ownership, REGNON avoids voting rights but offers crypto advantages like fast settlements. Critics note potential oracle risks for price feeds, yet Ondo's secure design, audited by firms like PeckShield, addresses these, making it a reliable RWA tool.
Regeneron Pharmaceuticals Tokenized Stock (Ondo) (token ticker REGNON) Price Prediction
Forecasting the price of Regeneron Pharmaceuticals Tokenized Stock (Ondo) (REGNON) involves analyzing its tie to REGN stock and broader market trends. Current data from CoinMarketCap shows REGNON at $745.53 USD, down 0.92% in 24 hours, reflecting biotech sector fluctuations. Analysts like those at Seeking Alpha predict REGN could rise 15-20% in 2026, driven by pipeline drugs, potentially boosting REGNON similarly. However, crypto volatility adds risks. For a detailed Regeneron Pharmaceuticals Tokenized Stock (Ondo) (REGNON) price prediction and forecast, visit WEEX to explore current data and future outlooks. Remember, predictions aren't guarantees; factors like regulatory changes or market downturns could impact values.
How Do You Buy Regeneron Pharmaceuticals Tokenized Stock (Ondo) (Abbreviation REGNON)?
Buying Regeneron Pharmaceuticals Tokenized Stock (Ondo) (REGNON) starts with selecting a reliable exchange. First, register on WEEX or log in on WEEX if you have an account. Once set up, deposit funds like USDT. Search for the REGNON/USDT pair and place a buy order at market or limit price. For step-by-step guidance, check out this how to buy Regeneron Pharmaceuticals Tokenized Stock (Ondo) guide on WEEX. Always verify wallet compatibility with Ethereum, as REGNON is ERC-20. Don't forget to enable two-factor authentication for security. Start small to understand fees and market dynamics before larger investments.
Official links
Social media and community
FAQ
1. What is the current price of Regeneron Pharmaceuticals Tokenized Stock (Ondo) (REGNon) in USD?
2. What is the market capitalization of Regeneron Pharmaceuticals Tokenized Stock (Ondo) (REGNon)?
3. What is the circulating supply of Regeneron Pharmaceuticals Tokenized Stock (Ondo) (REGNon)?
4. What factors influence the price of Regeneron Pharmaceuticals Tokenized Stock (Ondo) (REGNon)?
5. Is Regeneron Pharmaceuticals Tokenized Stock (Ondo) (REGNon) a good investment?
6. Where can I buy Regeneron Pharmaceuticals Tokenized Stock (Ondo) (REGNon)?
7. What are the typical fees when buying Regeneron Pharmaceuticals Tokenized Stock (Ondo) (REGNon)?
8. What are some technical indicators used for analyzing Regeneron Pharmaceuticals Tokenized Stock (Ondo) (REGNon)?
Currency price converter
Popular
Global prices
¥
₽
€
$
¥
NT$
₫
aed
₴
zł
R$
Rp
$
₼Regeneron Pharmaceuticals Tokenized Stock (Ondo) news
Meet the new WEEX trial fund—your gateway to greater profits
Discover WEEX's new trial fund and trade with less risk. Use them to offset transaction fees, funding fees, and trading losses. Kickoff your trading journey with WEEX!
WEEX Labs Lands at Dutch Blockchain Week: A Disruptive Crypto × AI Conversation Sets Sail in Amsterdam
WEEX Labs lands in Amsterdam for Dutch Blockchain Week with Agentic Day: The AI Infrastructure Economy — featuring a Cointelegraph exclusive interview with Waqar Zaka, a live AI trading competition (no code required, just natural language), and a keynote from WEEX COO Andrew Weiner. June 22. Register now: https://luma.com/lo977l6h
SK Hynix Reportedly Plans U.S. ADR Listing as Early as August, With SEC Approval Possible in Late June
SK Hynix may pursue a U.S. ADR listing as early as August, with SEC approval reportedly possible in late June amid strong AI chip supply chain demand.
SpaceX vs Tesla vs xAI: Which Elon Musk Trade Has the Biggest Upside in 2026?
SpaceX's IPO is days away, Tesla holds over 11,000 BTC, and xAI is betting big on AI. Here's how traders are comparing the three biggest Musk narratives.
OpenAI Reveals It Has Confidentially Submitted an S-1 to the SEC, Keeping the Door Open for a Future IPO
On June 9, according to an OpenAI announcement, the company recently confidentially submitted a draft S-1 registration statement to the U.S. Securities and Exchange Commission (SEC), beginning the preliminary compliance process for a potential initial public offering. OpenAI said it chose to disclose this proactively because it expected the news might leak; however, the company has not yet set a specific listing timeline, and related arrangements may still take some time.
Latest research from 13 top universities including Cornell University: The current state, challenges, and misconceptions of the fusion of Crypto and AI
The combination of AI and crypto is still in its early stages, with both serving as complementary "middleware": AI translates human intentions into executable programs, while cryptographic technology provides verifiable and tamper-proof guarantees for computational processes and results. In the dire...
Website
X(Twitter)









